MDHearing VoltMax vs Oticon Intent

The MDHearing VoltMax is a behind-the-ear OTC hearing aid priced at $699, earning a B grade with a SoundScore of 3.0/5 in our lab testing. This mid-priced device ranks #62 of 65 in the OTC Hearing Aid category, placing it in the bottom portion of tested products. In our standardized testing, the VoltMax demonstrates excellent feedback handling at 5.0/5, scoring 0.46 points above the category average. This means users are unlikely to experience whistling or squealing during typical wear. However, speech performance presents significant challenges—speech in quiet scores a low 1.9/5 (0.93 points below average), while speech in noise scores 1.0/5 (0.48 points below average). These results suggest limited benefit for understanding conversation in both calm and challenging listening environments. Music streaming is a notable weakness, scoring 0.0/5 and falling 1.92 points below the category average. Users who prioritize streaming audio content from their phones should consider alternatives. Own-voice comfort is mixed at 2.4/5, roughly matching the category average. At this price point, several alternatives offer substantially stronger performance. Devices like the Yeasound RIC800 and Sony CRE-E10 score above 4.5/5 at similar or lower prices. The VoltMax may appeal to users who prioritize feedback-free wear and basic amplification with rechargeable convenience, but those seeking stronger speech clarity should explore higher-performing options in this price range.

The Oticon Intent is a premium behind-the-ear prescription hearing aid released in 2024, priced at $4,898. With a SoundScore of 4.8/5 and an A grade, it ranks #3 among the 36 prescription hearing aids tested by HearAdvisor, placing it in the top 6% of its category. In our lab testing, the Intent delivers strong speech performance, scoring 1.10 points above the category average for speech in noise and 0.62 points above average for speech in quiet. Music streaming is a particular strength at 4.0/5, which is 1.36 points above the prescription hearing aid average—making it a solid choice for users who frequently stream audio from their phones. Feedback handling is excellent at 5.0/5, ensuring stable performance without whistling during everyday activities. The most notable limitation is own-voice comfort, which scores 1.3/5—a low result that falls 1.45 points below the category average. Users sensitive to how their own voice sounds while wearing hearing aids should be aware of this trade-off. The Intent includes rechargeable batteries, both iPhone and Android streaming, and hands-free calling capabilities. It has earned HearAdvisor's Expert's Choice Award in both 2023 and 2024. This hearing aid is best suited for users prioritizing speech clarity in challenging listening environments and high-quality audio streaming, who can accept the own-voice characteristics. Within its premium price tier, competitors like the Phonak Sphere Infinio (5.0/5) and Oticon Real (4.75/5) offer alternatives worth considering.